Skip to content
healthcare.dev

WAYRILZ

NDC 58468-0251, rilzabrutinib, tablet, film coated, from Genzyme Corporation.

Product NDC
58468-0251
Status
Listed
Labeler
Genzyme Corporation
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219685
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0251 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RILZABRUTINIB400 mg/1
Package NDCNDC-11Package
58468-0251-5584680251052 BLISTER PACK in 1 CARTON (58468-0251-5) / 28 TABLET, FILM COATED in 1 BLISTER PACK (58468-0251-0)
58468-0251-6584680251061 BOTTLE in 1 CARTON (58468-0251-6) / 60 TABLET, FILM COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/95ffd367-9b0c-4f75-8487-5d8f3c0a5ad0

Use it

Look up 58468-0251 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0251 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58468-0251. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.